Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer.
Författare
Summary, in English
Breast cancer (BC) is one of the leading causes of death among women worldwide. Immunostimulatory treatment has increasingly been used as adjuvant therapy in the last few years, in patients with melanoma and other cancer forms, often with an induction of autoimmunity as a consequence of a successful treatment. We aimed at investigating if coexisting autoimmune diseases (AD) or hypersensitivities (HS) similarly to the side effects of immunostimulatory treatment resulted in a better overall survival, compared to patients without these disorders.
Avdelning/ar
- Bröstcancer-genetik
- EpiHealth: Epidemiology for Health
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2013
Språk
Engelska
Publikation/Tidskrift/Serie
SpringerPlus
Volym
2
Fulltext
- Available as PDF - 561 kB
- Download statistics
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
Springer
Ämne
- Cancer and Oncology
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 2193-1801